In July 2024, Dr Gloria Gonzalez-Aseguinolaza, Chief Scientific Officer of Vivet Therapeutics, received the Rosalind Franklin Society Special Award in Science. DDW’s Diana Spencer caught up with her about her career in gene therapy. DS: Can you tell us what you do and what you’re working on at the moment?  GG-A: As the co-founder and […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!